Simple DNA test could predict bladder cancer recurrence
NCT ID NCT07424560
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is developing a new DNA test that looks for key genetic changes in bladder cancer tumors. Researchers will collect tumor samples from 400 patients to build and validate the test. The goal is to create a cost-effective tool that helps doctors predict which patients are at higher risk of recurrence and tailor treatments accordingly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Multiplex mutation detection system (nucleic acid mass spectrometry)
- What this could lead to
- If successful, this could lead to a simple, affordable DNA test that helps doctors predict bladder cancer recurrence and choose the best treatment for each patient.
- What could go wrong
- This is an early-stage study focused on developing and validating the test, not yet proving it improves patient outcomes. The test may not be accurate enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADJUVANT THERAPY FOR BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Hospital of Lanzhou University
RECRUITINGLanzhou, Gansu, 730030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bag-Like device pull bladder tumors out whole?
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Bladder cancer: a new combo aims to avoid radical surgery
- Could a simple urine test spare bladder cancer patients from chemotherapy?
- Can a new drug rally the immune system against Hard-to-Treat cancers?
- Can One-Piece tumour removal improve bladder cancer outcomes?